US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Liminatus Pharma, Inc. - Class A Common Stock (NQ:LIMN)

3.900 +0.150 (+4.00%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Liminatus Pharma, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 Next >
Which stocks are gapping on Wednesday? ↗
Via Chartmill
News headline image
Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds
From Liminatus Pharma Inc.
Via GlobeNewswire
Which stocks are experiencing notable movement on Friday? ↗
Via Chartmill
Unusual volume stocks in Friday's session ↗
Via Chartmill
Unusual volume stocks in Thursday's session ↗
Via Chartmill
Keep an eye on the top gainers and losers in Friday's session. ↗
Via Chartmill
Friday's session: gap up and gap down stocks ↗
Via Chartmill
Discover the top movers in Friday's pre-market session. ↗
Via Chartmill
News headline image
Liminatus Pharma Announces Nasdaq Delisting Notification
From Liminatus Pharma Inc.
Via GlobeNewswire
Most active stocks in Thursday's session ↗
Via Chartmill
Here are the top movers in Thursday's session. ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
Liminatus Pharma Announces Proposed Merger with InnocsAI to Expand Oncology Cell Therapy Pipeline
Transaction Adds Clinical and Preclinical CAR-T Programs Targeting Hematologic Malignancies and Solid Tumors 
From Liminatus Pharma Inc.
Via GlobeNewswire
News headline image
Which stocks are most active on Wednesday? ↗
These stocks are making the most noise in today's session. Stay tuned for the latest updates! 
Via Chartmill
Topics Artificial Intelligence
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody
From Liminatus Pharma Inc.
Via GlobeNewswire
Top movers analysis one hour before the close of the markets on 2026-02-17: top gainers and losers in today's session. ↗
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
Tuesday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering
From Liminatus Pharma, Inc.
Via GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Which stocks are experiencing notable movement on Wednesday? ↗
Via Chartmill
On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
On Monday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
Via Chartmill
Unusual volume stocks in Friday's session ↗
Via Chartmill
Here are the top movers in Thursday's session. ↗
Via Chartmill
< Previous 1 2 3 4 5 Next >